◆ NeutralAZNLLYMRNAMRKAMGNRHHBY
Breakfast News: Science Strikes Back at Cancer
The Motley Fool·
Cancer treatment breakthroughs dominate ESMO 2026 conference with multiple drugs showing significant survival gains. U.S. stocks declined amid AI spending concerns and rising oil prices, with the Fed expected to hold rates steady Wednesday. Several Motley Fool-recommended companies report earnings this week including Alphabet, Amazon, and Mastercard. TransDigm's stock decline reflects valuation compression rather than business deterioration.
Read Full Article at The Motley Fool →